Inventor · disambiguated record
Svante Hermodsson
Also filed as: HERMODSSON SVANTE · HERMODSSON SVANTE H · HERMODSSON SVANTE HERMOD
21 granted patents·10 pending applications·198 citations·filing 1992–2005
95Inventor score
Top patents by PatentIndex Score
31 records- 0183US6407133B2Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 2001·Granted Jun 18, 2002·12 cites·7 claims
- 0281US6242473B1Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 1999·Granted Jun 5, 2001·33 cites·12 claims
- 0378US6893633B2Methods and compositions for promoting the maturation of monocytesMAXIM PHARM INC·Filed 2002·Granted May 17, 2005·8 cites·15 claims
- 0477US6790440B2Methods and compositions for promoting the maturation of monocytesMAXIM PHARM INC·Filed 2002·Granted Sep 14, 2004·7 cites·9 claims
- 0577US6305380B1Method for treatment of cancer and infectious diseaseMAXIM PHARM INC·Filed 2000·Granted Oct 23, 2001·8 cites·18 claims
- 0674US6730692B2Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 2002·Granted May 4, 2004·4 cites·13 claims
- 0774US6375946B1Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitorMAXIM PHARM INC·Filed 2000·Granted Apr 23, 2002·4 cites·16 claims
- 0872US6462067B1Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 2000·Granted Oct 8, 2002·3 cites·18 claims
- 0971US6613788B1Elevation of circulating blood histamine levelsMAXIM PHARM INC·Filed 2000·Granted Sep 2, 2003·2 cites·22 claims
- 1070US6821510B2Methods and compositions for promoting the maturation of monocytesMAXIM PHARM INC·Filed 2002·Granted Nov 23, 2004·3 cites·10 claims
- 1170US6245563B1Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitorMAXIM PHARM INC·Filed 2000·Granted Jun 12, 2001·2 cites·5 claims
- 1270US6063373AEnhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitorMAXIM PHARM INC·Filed 1997·Granted May 16, 2000·33 cites·5 claims
- 1360US5728378APreparation for activation of natural killer cells (NK-cells), said preparation containing interferon-alpha and histamine, serotonin, amines or substances with corresponding receptor activityMAXIM PHARM INC·Filed 1993·Granted Mar 17, 1998·23 cites·15 claims
- 1458US5348739ACombined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H2 -receptor agonistsSYNTELLO INC·Filed 1992·Granted Sep 20, 1994·17 cites·23 claims
- 1558US2004191239A1Treatment and prevention of reactive oxygen metabolite-mediated cellular damageFiled 2004·Application pending·0 cites
- 1655US2002119119A1Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitorFiled 2002·Application pending·0 cites
- 1755US2004219153A1Synergistic tumorcidal response induced by histamineFiled 2004·Application pending·0 cites
- 1854US6071942AElevation of circulating blood histamine levelsMAXIM PHARM INC·Filed 1997·Granted Jun 6, 2000·9 cites·9 claims
- 1954US2003017145A1Treatment and prevention of reactive oxygen metabolite-mediated cellular damageFiled 2002·Application pending·0 cites
- 2052US6498181B1Synergistic tumorcidal response induced by histamineMAXIM PHARMACEUTICALS·Filed 1999·Granted Dec 24, 2002·8 cites·1 claims
- 2151US2002094323A1Methods and compositions for promoting the maturation of monocytesFiled 2001·Application pending·0 cites
- 2251US2002193416A1Synergistic tumorcidal response induced by histamineFiled 2002·Application pending·0 cites
- 2349US2002035998A1Method for treatment of cancer and infectious diseaseFiled 2001·Application pending·0 cites
- 2446US5961969AStable circulating histamine levelsMAXIM PHARM INC·Filed 1996·Granted Oct 5, 1999·8 cites·37 claims
- 2545US2004120926A1Reactive oxygen metabolite inhibitors for use in compositions and methods of treatmentFiled 2003·Application pending·0 cites
- 2643US6155266AMethod for treatment of cancer and infectious diseaseMAXIM PHARM INC·Filed 1999·Granted Dec 5, 2000·3 cites·9 claims
- 2742US2003039628A1Activation and protection of T-cells (CD4+ and CD8+) using an H2 receptor agonist and other T-cell activating agentsFiled 2002·Application pending·0 cites
- 2842US2006079510A1Use of PARP-1 inhibitors for protecting tumorcidal lymphocytes from apoptosisHELLSTRAND KRISTOFFER·Filed 2005·Application pending·0 cites
- 2941US6221893B1Administration of histamine for therapeutic purposesMAXIM PHARM INC·Filed 1996·Granted Apr 24, 2001·5 cites·23 claims
- 3041US6071509AEnhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitorMAXIM PHARM INC·Filed 1996·Granted Jun 6, 2000·5 cites·16 claims
- 3133US6003516AMethod for treatment of cancer and infectious diseaseMAXIM PHARM INC·Filed 1998·Granted Dec 21, 1999·1 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Svante Hermodsson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →